M-CERSI Innovation Awards

In 2013-2014, the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) awarded two Innovation Awards, and five Innovations in Minority Health Awards. M-CERSI Innovations in Minority Health Awards are similar to Innovation Awards and additionally aim to address racial and ethnic health disparities.

Below are the two Innovation Award project recipients:

Absolute Protein and Protein Aggregate Concentration Measurement

This project, led by Dr. Michael Zachariah, focuses on demonstrating electrospay differential mobility analysis (ES-DMA) as a tool to quantify protein aggregation, and as an absolute number concentration primary standard for protein with a projected uncertainty of <5%.

Development of Computational Models to Predict Drug-Induced Liver Injury (DILI)

Dr. Peter Swaan and Dr. Hongbing Wang aim to develop and validate models that integrate all three transporters in a web-based environment that can be accessed by investigators in academia, industry, and the FDA.

Below are the five Minority Health awardees:

Addressing Chronic Disease Healthcare Disparities through the Patient-Centric Design of Health Information Technology

Dr. Monifa Vaughn-Cooke's research introduces a new paradigm of HIT that empowers patients to be more involved in their chronic disease management through enhanced patient-provider communication and shared treatment decision-making.

Improving Health Literacy and Cultural Competency in Current FDA Risk Communication

This project is led by Dr. Olivia Carter-Pokras, Department of Epidemiology and Biostatistics.

Racial/Ethnic Differences in Pediatric Antipsychotic Use by FDA Labeled Status

Dr. Julie Zito aims to study  antipsychotic use in youth in relation to racial/ethnic differences, insurance type, and FDA labeled indication for use.

Qualitative Focus Group Studies: Clinical Trial Participation and Biospecimen (Tissue) Donation for Research

Barriers, Willingness to Participate in Clinical Trials, Willingness to Donate to Biobanks, and Informed Consent Preferences Among Rural and Urban Residents in Maryland's Eastern Shore, Rural Southern Shore, and Urban Baltimore City

Dr. Claudia Baquet (University of Maryland Baltimore School of Medicine) is leading an investigation on underserved populations that are underrepresented in clinical trial and biospecimen donation; that is, rural and urban communities in Maryland.

Investigating Factors Associated with Participating of Racial & Ethnic Minority POpulations in FDA Regulated Research

Dr. Sandra Crouse Quinn (School of Public Health) aims to ensure adequate representation of minorities in industry trials of drugs and devices and to strengthen the capacity of industry investigators to recruit and retain minority participants.